News
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...
8d
GlobalData on MSNThe GLP-1 drug shortage is over. What’s next for the compounders?Tirzepatide is sold under the brand names Mounjaro and Zepbound for T2D treatment and weight loss, respectively. Compounded ...
Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...
Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government ...
3d
India Today on MSNWeight-loss drugs linked to poor mental health in new studyInitially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight-reducing effects.
INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide ... opposed to getting the brand name, Ozempic or Mounjaro for example, from their local pharmacy.
6d
Tampa Free Press on MSNBeware The Imitation: The Growing Danger of Counterfeit And Compounded GLP-1 MedicationsGLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results